Literature DB >> 25697518

The rhodopsin-arrestin-1 interaction in bicelles.

Qiuyan Chen1, Sergey A Vishnivetskiy, Tiandi Zhuang, Min-Kyu Cho, Tarjani M Thaker, Charles R Sanders, Vsevolod V Gurevich, T M Iverson.   

Abstract

G-protein-coupled receptors (GPCRs) are essential mediators of information transfer in eukaryotic cells. Interactions between GPCRs and their binding partners modulate the signaling process. For example, the interaction between GPCR and cognate G protein initiates the signal, while the interaction with cognate arrestin terminates G-protein-mediated signaling. In visual signal transduction, arrestin-1 selectively binds to the phosphorylated light-activated GPCR rhodopsin to terminate rhodopsin signaling. Under physiological conditions, the rhodopsin-arrestin-1 interaction occurs in highly specialized disk membrane in which rhodopsin resides. This membrane is replaced with mimetics when working with purified proteins. While detergents are commonly used as membrane mimetics, most detergents denature arrestin-1, preventing biochemical studies of this interaction. In contrast, bicelles provide a suitable alternative medium. An advantage of bicelles is that they contain lipids, which have been shown to be necessary for normal rhodopsin-arrestin-1 interaction. Here we describe how to reconstitute rhodopsin into bicelles, and how bicelle properties affect the rhodopsin-arrestin-1 interaction.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25697518      PMCID: PMC4520306          DOI: 10.1007/978-1-4939-2330-4_6

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  52 in total

1.  Arrestin: mutagenesis, expression, purification, and functional characterization.

Authors:  V V Gurevich; J L Benovic
Journal:  Methods Enzymol       Date:  2000       Impact factor: 1.600

2.  The 2.8 A crystal structure of visual arrestin: a model for arrestin's regulation.

Authors:  J A Hirsch; C Schubert; V V Gurevich; P B Sigler
Journal:  Cell       Date:  1999-04-16       Impact factor: 41.582

3.  Crystal structure of rhodopsin: A G protein-coupled receptor.

Authors:  K Palczewski; T Kumasaka; T Hori; C A Behnke; H Motoshima; B A Fox; I Le Trong; D C Teller; T Okada; R E Stenkamp; M Yamamoto; M Miyano
Journal:  Science       Date:  2000-08-04       Impact factor: 47.728

4.  An additional phosphate-binding element in arrestin molecule. Implications for the mechanism of arrestin activation.

Authors:  S A Vishnivetskiy; C Schubert; G C Climaco; Y V Gurevich; M G Velez; V V Gurevich
Journal:  J Biol Chem       Date:  2000-12-29       Impact factor: 5.157

5.  Cell-free expression of visual arrestin. Truncation mutagenesis identifies multiple domains involved in rhodopsin interaction.

Authors:  V V Gurevich; J L Benovic
Journal:  J Biol Chem       Date:  1992-10-25       Impact factor: 5.157

6.  Using NMRView to visualize and analyze the NMR spectra of macromolecules.

Authors:  Bruce A Johnson
Journal:  Methods Mol Biol       Date:  2004

Review 7.  The molecular acrobatics of arrestin activation.

Authors:  Vsevolod V Gurevich; Eugenia V Gurevich
Journal:  Trends Pharmacol Sci       Date:  2004-02       Impact factor: 14.819

8.  Structure and function in rhodopsin: kinetic studies of retinal binding to purified opsin mutants in defined phospholipid-detergent mixtures serve as probes of the retinal binding pocket.

Authors:  P J Reeves; J Hwa; H G Khorana
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

Review 9.  Methyl groups as probes of structure and dynamics in NMR studies of high-molecular-weight proteins.

Authors:  Vitali Tugarinov; Lewis E Kay
Journal:  Chembiochem       Date:  2005-09       Impact factor: 3.164

10.  How does arrestin respond to the phosphorylated state of rhodopsin?

Authors:  S A Vishnivetskiy; C L Paz; C Schubert; J A Hirsch; P B Sigler; V V Gurevich
Journal:  J Biol Chem       Date:  1999-04-23       Impact factor: 5.157

View more
  1 in total

Review 1.  Biased GPCR signaling: Possible mechanisms and inherent limitations.

Authors:  Vsevolod V Gurevich; Eugenia V Gurevich
Journal:  Pharmacol Ther       Date:  2020-03-19       Impact factor: 12.310

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.